Gleamer vs Rayscape (2026)
Two European radiograph companies reading different films for different departments. Gleamer is trauma first, detecting fractures, effusions and dislocations with a clearance covering adult and paediatric use that is reported to be unique in that segment, aimed at the overnight emergency queue where a missed finding most reliably becomes a complaint. Rayscape is chest first, with a large findings set, longitudinal comparison against prior scans and independent evaluation from a tuberculosis screening deployment. A department choosing between them is choosing which reading burden to attack rather than which vendor is better. Ask each for performance on your own case mix, because prevalence changes the false positive burden more than published sensitivity does.
- Its fracture detection clearance covers both adult and paediatric use, reported to be unique in that segment, with a strong clearance study design behind it.
- Trauma radiography is the highest volume plain film reading in any emergency department and the one where a missed finding most often becomes a claim.
- Distribution runs directly and through several imaging platform partners, so adoption does not depend on one integration path.
- Chest coverage is broad with longitudinal comparison against a patient's prior scans, plus lung nodule work on computed tomography.
- Independent evaluation in a tuberculosis screening context is a harder test than a retrospective reader study.
- On premise and cloud integration are both offered, which matters where images cannot leave the institution.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Gleamer and Rayscape are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Gleamer | Rayscape |
|---|---|---|
| Primary category | Radiology & Imaging AI | Radiology & Imaging AI |
| Founded | 2017 | 2019 |
| Headquarters | Paris, France | Timisoara, Romania |
| Website | gleamer.ai | rayscape.ai |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Gleamer its top capability grade on AI Centrality, Clinical and Operational Evidence and FDA and Regulatory Status. Set against Rayscape, Gleamer grades higher on Clinical and Operational Evidence and FDA and Regulatory Status. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards Rayscape its top capability grade on AI Centrality. Set against Gleamer, Rayscape grades higher on several axes, including Model Supply Chain Disclosure, AI Safety and PHI Stewardship and HIPAA and BAA Posture. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Gleamer or Rayscape?
On the axes where the AI Health Index separates them, Gleamer grades higher on Clinical and Operational Evidence and FDA and Regulatory Status, and Rayscape grades higher on several axes, including Model Supply Chain Disclosure, AI Safety and PHI Stewardship and HIPAA and BAA Posture. Rayscape leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do Gleamer and Rayscape differ most?
The widest separation the AI Health Index records between Gleamer and Rayscape is on FDA and Regulatory Status, where Gleamer grades A and Rayscape grades C. That axis sits in the Regulatory and Compliance group, so it should carry the most weight for a buyer whose binding constraint is where regulatory exposure sits and who carries it.
Where do Gleamer and Rayscape grade the same?
The AI Health Index grades Gleamer and Rayscape the same on several axes, including AI Centrality, Autonomy and Oversight Model and Model and Technology Transparency. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Decision Support page.
Compare these per body region and per finding rather than on aggregate claims, since a trauma product and a chest product share almost no performance surface and their findings counts are not comparable. Neither publishes a security attestation or trust centre, which this index records as a pattern across non United States imaging vendors rather than a fault of either. Gleamer's multi party distribution makes data stewardship harder to answer, since the responsible party varies by delivery path and no business associate terms were located.